Institut de Cardiologie de Montréal, centre de recherche, 5000 rue Bélanger, Montréal, Québec, Canada.
Am J Physiol Regul Integr Comp Physiol. 2010 May;298(5):R1188-94. doi: 10.1152/ajpregu.00653.2009. Epub 2010 Mar 17.
Endogenous endothelin-1-dependent (ET-1) tone in coronary arteries depends on the balance between ET(A) and ET(B) receptor-mediated effects and on parameters such as receptor distribution and endothelial integrity. Numerous studies highlight the striking functional interactions that exist between nitric oxide (NO) and ET-1 in the regulation of vascular tone. Many of the cardiovascular complications associated with cardiovascular risk factors and aging are initially attributable, at least in part, to endothelial dysfunction characterized by a dysregulation between NO and ET-1. The contribution of the imbalance between smooth muscle ET(A/B) and endothelial ET(B) receptors to this process is poorly understood. An increased contribution of ET-1 that is associated with a proportional decrease in that of NO accompanies the development of coronary endothelial dysfunction, coronary vasospasm, and atherosclerosis. These data form the basis for the rationale of testing therapeutic approaches counteracting ET-1-induced cardiovascular dysfunction. It remains to be determined whether the beneficial role of endothelial ET(B) receptors declines with age and risk factors for cardiovascular diseases, revealing smooth muscle ET(B) receptors with proconstricting and proinflammatory activities.
冠状动脉内源性内皮素-1 依赖性(ET-1)张力取决于 ET(A)和 ET(B)受体介导的作用之间的平衡,以及受体分布和内皮完整性等参数。许多研究强调了在血管张力调节中存在着一氧化氮(NO)和 ET-1 之间惊人的功能相互作用。与心血管危险因素和衰老相关的许多心血管并发症最初至少部分归因于内皮功能障碍,其特征是 NO 和 ET-1 之间的失调。平滑肌 ET(A/B)和内皮 ET(B)受体之间的失衡对这一过程的贡献知之甚少。与 NO 的比例下降相伴的是 ET-1 贡献的增加,这伴随着冠状动脉内皮功能障碍、冠状动脉痉挛和动脉粥样硬化的发展。这些数据为测试对抗 ET-1 诱导的心血管功能障碍的治疗方法提供了依据。内皮 ET(B)受体的有益作用是否会随着年龄和心血管疾病的危险因素而下降,从而揭示具有促收缩和促炎活性的平滑肌 ET(B)受体,仍有待确定。